Cargando…

Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia

Our case report demonstrates the use of phase contrast magnetic resonance imaging (MRI) in monitoring the functional status of liver vasculature in a patient with hereditary hemorrhagic telangiectasia (HHT) who was treated with bevacizumab. Our report provides additional information that can be furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutaiba, Numan, Gow, Paul J, French, Janine, Lim, Ruth P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317208/
https://www.ncbi.nlm.nih.gov/pubmed/25678970
http://dx.doi.org/10.1002/ccr3.141
_version_ 1782355679345901568
author Kutaiba, Numan
Gow, Paul J
French, Janine
Lim, Ruth P
author_facet Kutaiba, Numan
Gow, Paul J
French, Janine
Lim, Ruth P
author_sort Kutaiba, Numan
collection PubMed
description Our case report demonstrates the use of phase contrast magnetic resonance imaging (MRI) in monitoring the functional status of liver vasculature in a patient with hereditary hemorrhagic telangiectasia (HHT) who was treated with bevacizumab. Our report provides additional information that can be further utilized in clinical settings and research.
format Online
Article
Text
id pubmed-4317208
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43172082015-02-12 Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia Kutaiba, Numan Gow, Paul J French, Janine Lim, Ruth P Clin Case Rep Case Reports Our case report demonstrates the use of phase contrast magnetic resonance imaging (MRI) in monitoring the functional status of liver vasculature in a patient with hereditary hemorrhagic telangiectasia (HHT) who was treated with bevacizumab. Our report provides additional information that can be further utilized in clinical settings and research. BlackWell Publishing Ltd 2015-01 2014-11-17 /pmc/articles/PMC4317208/ /pubmed/25678970 http://dx.doi.org/10.1002/ccr3.141 Text en © 2014 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Kutaiba, Numan
Gow, Paul J
French, Janine
Lim, Ruth P
Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
title Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
title_full Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
title_fullStr Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
title_full_unstemmed Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
title_short Putting a new spin: MRI monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
title_sort putting a new spin: mri monitoring of hepatic artery and portal vein flow for response to bevacizumab in hereditary hemorrhagic telangiectasia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317208/
https://www.ncbi.nlm.nih.gov/pubmed/25678970
http://dx.doi.org/10.1002/ccr3.141
work_keys_str_mv AT kutaibanuman puttinganewspinmrimonitoringofhepaticarteryandportalveinflowforresponsetobevacizumabinhereditaryhemorrhagictelangiectasia
AT gowpaulj puttinganewspinmrimonitoringofhepaticarteryandportalveinflowforresponsetobevacizumabinhereditaryhemorrhagictelangiectasia
AT frenchjanine puttinganewspinmrimonitoringofhepaticarteryandportalveinflowforresponsetobevacizumabinhereditaryhemorrhagictelangiectasia
AT limruthp puttinganewspinmrimonitoringofhepaticarteryandportalveinflowforresponsetobevacizumabinhereditaryhemorrhagictelangiectasia